Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pyxis Genomics was a biotechnology company focused on the application of genomics to animal health and livestock production. Founded in 2000, the company developed a proprietary platform to identify genetic markers associated with economically important traits in livestock, such as disease resistance, growth rate, and meat quality. By leveraging comparative genomics, Pyxis aimed to accelerate selective breeding programs and improve the efficiency of animal agriculture. The company's technology was primarily applied to swine and cattle, providing genomic tools for the livestock industry. Pyxis Genomics was acquired by Newsham Genetics in 2003, which integrated its genomic capabilities into its commercial breeding operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pyxis Genomics.